These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2163359)

  • 21. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety.
    Noyes R; DuPont RL; Pecknold JC; Rifkin A; Rubin RT; Swinson RP; Ballenger JC; Burrows GD
    Arch Gen Psychiatry; 1988 May; 45(5):423-8. PubMed ID: 3358644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Panic attack syndrome.
    Van Winter JT; Stickler GB
    J Pediatr; 1984 Oct; 105(4):661-5. PubMed ID: 6481547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction in hypochondriasis with treatment of panic disorder.
    Noyes R; Reich J; Clancy J; O'Gorman TW
    Br J Psychiatry; 1986 Nov; 149():631-5. PubMed ID: 3814956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Secondary depression in panic disorder and agoraphobia. I. Frequency, severity, and response to treatment.
    Lesser IM; Rubin RT; Pecknold JC; Rifkin A; Swinson RP; Lydiard RB; Burrows GD; Noyes R; DuPont RL
    Arch Gen Psychiatry; 1988 May; 45(5):437-43. PubMed ID: 3282480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HPA axis disturbance and treatment outcome in panic disorder.
    Coryell W; Noyes R
    Biol Psychiatry; 1988 Nov; 24(7):762-6. PubMed ID: 3067754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term effects of alprazolam and imipramine on cerebrospinal fluid monoamine metabolites and neuropeptides in panic disorder.
    Lepola U; Jolkkonen J; Rimón R; Riekkinen P
    Neuropsychobiology; 1989; 21(4):182-6. PubMed ID: 2483580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Panic and phobic disorders--are psychological or pharmacological treatments effective?
    Judd FK; Burrows GD
    Aust N Z J Psychiatry; 1986 Sep; 20(3):342-8. PubMed ID: 3467713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clonazepam in the treatment of panic disorder and agoraphobia.
    Pollack MH; Rosenbaum JF; Tesar GE; Herman JB; Sachs GS
    Psychopharmacol Bull; 1987; 23(1):141-4. PubMed ID: 3110854
    [No Abstract]   [Full Text] [Related]  

  • 29. Panic attacks in phobia treatment studies.
    Arch Gen Psychiatry; 1983 Oct; 40(10):1150-2. PubMed ID: 6625865
    [No Abstract]   [Full Text] [Related]  

  • 30. Emergence of depressive symptoms in patients receiving alprazolam for panic disorder.
    Lydiard RB; Laraia MT; Ballenger JC; Howell EF
    Am J Psychiatry; 1987 May; 144(5):664-5. PubMed ID: 3578580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of panic and agoraphobia. An integrative review.
    Mattick RP; Andrews G; Hadzi-Pavlovic D; Christensen H
    J Nerv Ment Dis; 1990 Sep; 178(9):567-76. PubMed ID: 2144315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NIMH collaborative research on treatment of depression.
    Klein DF
    Arch Gen Psychiatry; 1990 Jul; 47(7):682-8. PubMed ID: 2163248
    [No Abstract]   [Full Text] [Related]  

  • 33. Double-blind comparison of alprazolam and adinazolam for panic and phobic disorders.
    Pyke RE; Greenberg HS
    J Clin Psychopharmacol; 1989 Feb; 9(1):15-21. PubMed ID: 2651489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Taper withdrawal studies with alprazolam in patients with panic disorder and agoraphobia.
    Pecknold JC; Swinson RP
    Psychopharmacol Bull; 1986; 22(1):173-6. PubMed ID: 3726063
    [No Abstract]   [Full Text] [Related]  

  • 35. Patients with panic disorder unaccompanied by depression improve with alprazolam and imipramine treatment.
    Deltito JA; Argyle N; Klerman GL
    J Clin Psychiatry; 1991 Mar; 52(3):121-7. PubMed ID: 2005075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of phobias. I. Comparison of imipramine hydrochloride and placebo.
    Zitrin CM; Klein DF; Woerner MG; Ross DC
    Arch Gen Psychiatry; 1983 Feb; 40(2):125-38. PubMed ID: 6337578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparison of the effect of alprazolam, imipramine and placebo in the treatment of panic disorders in Cali, Colombia].
    León CA; De Arango MV; Arevalo W; Calvo A; Montoya A; León A
    Acta Psiquiatr Psicol Am Lat; 1990; 36(1-2):59-72. PubMed ID: 2073024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benzodiazepine treatment of panic disorder: a comparison of alprazolam and lorazepam.
    Charney DS; Woods SW
    J Clin Psychiatry; 1989 Nov; 50(11):418-23. PubMed ID: 2808308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. III. Discontinuation effects.
    Pecknold JC; Swinson RP; Kuch K; Lewis CP
    Arch Gen Psychiatry; 1988 May; 45(5):429-36. PubMed ID: 3282479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical response to clonidine and imipramine, and platelet alpha 2-adrenoreceptors in a case of agoraphobia with panic attacks.
    Zelnik TC; Garcia-Sevilla JA; Cameron OG; Smith CB
    Biol Psychiatry; 1982 Jun; 17(6):761-6. PubMed ID: 6285996
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.